AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
Amikacin Sulphate Equivalent To Amikacin
12 registrations across 1 African market— 6 active
Markets with Amikacin Sulphate Equivalent To Amikacin
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| AMIKACIN 500 mg/2 ml EMCURE | 🇿🇦South Africa | Emcure- Pharmaceutical South Africa (Pty) Ltd | active | Jul 2029 |
| AMOGLACIN 1,0 g/4 ml | 🇿🇦South Africa | Emcure- Pharmaceutical South Africa (Pty) Ltd | active | Jul 2029 |
| AMIKACIN 500 1 g/4 ml EMCURE | 🇿🇦South Africa | Emcure- Pharmaceutical South Africa (Pty) Ltd | active | Jul 2029 |
| AMOGLACIN 500 mg/2 ml | 🇿🇦South Africa | Emcure- Pharmaceutical South Africa (Pty) Ltd | active | Jul 2029 |
| CIPLA AMIKACIN 500 | 🇿🇦South Africa | Cipla Medpro (Pty) Ltd | suspended | Sept 2025 |
| MEDPRO AMIKACIN 250 | 🇿🇦South Africa | Cipla Medpro (Pty) Ltd | suspended | Jul 2025 |
| MEDPRO AMIKACIN 500 | 🇿🇦South Africa | Cipla Medpro (Pty) Ltd | suspended | Jul 2025 |
| CIPLA AMIKACIN 100 | 🇿🇦South Africa | Cipla Medpro (Pty) Ltd | suspended | Jul 2025 |
| CIPLA AMIKACIN 250 | 🇿🇦South Africa | Cipla Medpro (Pty) Ltd | suspended | Jul 2025 |
| MEDPRO AMIKACIN 100 | 🇿🇦South Africa | Cipla Medpro (Pty) Ltd | suspended | Jul 2025 |
| ASPEN AMIKACIN 100 mg/2 ml | 🇿🇦South Africa | Pharmacare Limited û Woodmead | active | Jan 1900 |
| ASPEN AMIKACIN 500 mg/2 ml | 🇿🇦South Africa | Pharmacare Limited û Woodmead | active | Jan 1900 |
Amikacin Sulphate Equivalent To Amikacin in Africa — Regulatory Overview
Amikacin Sulphate Equivalent To Amikacin is registered across 1 African markets with 12 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including South Africa. AfricaRegulatory refreshes this data daily from official government sources.
Of the 12 registrations, 6 (50%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.